See today's BioWorld Science
To read the full story, subscribe or sign in.
Endocrine/Metabolic

Abliva’s NV-354 awarded US orphan drug designation for mitochondrial disease

April 18, 2023
Abliva AB’s NV-354 has been granted orphan drug designation by the FDA for the treatment of mitochondrial disease.
BioWorld Science Endocrine/metabolic FDA Orphan drug